Alopecia areata : review of epidemiology, pathophysiology, current treatments and nanoparticulate delivery system
Alopecia areata (AA) is a kind of alopecia that affects hair follicles and nails. It typically comes with round patches and is a type of nonscarring hair loss. Various therapies are accessible for the management and treatment of AA, including topical, systemic and injectable modalities. It is a very complex type of autoimmune disease and is identified as round patches of hair loss and may occur at any age. This review paper highlights the epidemiology, clinical features, pathogenesis and new treatment options for AA, with a specific emphasis on nanoparticulate drug-delivery systems. By exploring these innovative treatment approaches, researchers aim to enhance the effectiveness and targeted delivery of therapeutic agents, ultimately improving outcomes for individuals living with AA.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Therapeutic delivery - 15(2024), 3 vom: 07. März, Seite 193-210 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Singh, Robel [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Alopecia areata |
|---|
| Anmerkungen: |
Date Completed 11.03.2024 Date Revised 11.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.4155/tde-2023-0071 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369391837 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369391837 | ||
| 003 | DE-627 | ||
| 005 | 20240311232529.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240307s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4155/tde-2023-0071 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1323.xml |
| 035 | |a (DE-627)NLM369391837 | ||
| 035 | |a (NLM)38449420 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Singh, Robel |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Alopecia areata |b review of epidemiology, pathophysiology, current treatments and nanoparticulate delivery system |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.03.2024 | ||
| 500 | |a Date Revised 11.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Alopecia areata (AA) is a kind of alopecia that affects hair follicles and nails. It typically comes with round patches and is a type of nonscarring hair loss. Various therapies are accessible for the management and treatment of AA, including topical, systemic and injectable modalities. It is a very complex type of autoimmune disease and is identified as round patches of hair loss and may occur at any age. This review paper highlights the epidemiology, clinical features, pathogenesis and new treatment options for AA, with a specific emphasis on nanoparticulate drug-delivery systems. By exploring these innovative treatment approaches, researchers aim to enhance the effectiveness and targeted delivery of therapeutic agents, ultimately improving outcomes for individuals living with AA | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Injectable modalities | |
| 650 | 4 | |a alopecia areata | |
| 650 | 4 | |a auto-immune disorder | |
| 650 | 4 | |a clobetasol propionate | |
| 650 | 4 | |a exuberate | |
| 650 | 4 | |a nanoparticulate drug delivery | |
| 650 | 4 | |a nonscarring | |
| 650 | 4 | |a systemic illness | |
| 700 | 1 | |a Kumar, Pawan |e verfasserin |4 aut | |
| 700 | 1 | |a Kumar, Davinder |e verfasserin |4 aut | |
| 700 | 1 | |a Aggarwal, Navidha |e verfasserin |4 aut | |
| 700 | 1 | |a Chopra, Hitesh |e verfasserin |4 aut | |
| 700 | 1 | |a Kumar, Virender |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Therapeutic delivery |d 2010 |g 15(2024), 3 vom: 07. März, Seite 193-210 |w (DE-627)NLM203937082 |x 2041-6008 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2024 |g number:3 |g day:07 |g month:03 |g pages:193-210 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4155/tde-2023-0071 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2024 |e 3 |b 07 |c 03 |h 193-210 | ||